x

Rechercher un test diagnostique

* (*) Champ obligatoire

81 Résultat(s)

Filtrer par

Spécialité(s)/Objectif(s)

Technique(s)

Contexte(s)

Management de la qualité

Pays

Reset
Trier par

Légende : Accréditation =Accréditation
;

ALLEMAGNE

Nordrhein-Westfalen
DÜSSELDORF

ALLEMAGNE

Baden-Württemberg
MANNHEIM

ALLEMAGNE

Bayern
MÜNCHEN

ALLEMAGNE

Sachsen
LEIPZIG

ALLEMAGNE

Rheinland-Pfalz
INGELHEIM AM RHEIN

ALLEMAGNE

Hessen
BAD NAUHEIM

ALLEMAGNE

Niedersachsen
HANNOVER

ROYAUME-UNI

West Midlands
BIRMINGHAM

Accréditation
Molecular diagnosis of Muir-Torre Syndrome (MLH1, MSH2 genes)
Birmingham Women's NHS Foundation Trust

ALLEMAGNE

Mecklenburg-Vorpommern
GREIFSWALD

Accréditation
Molecular diagnosis of familial nonpolyposis colon cancer (MLH1, MSH2, MSH6, PMS2 genes)
Institut für Humangenetik der Universitätsmedizin Greifswald

ALLEMAGNE

Baden-Württemberg
TÜBINGEN

Accréditation
Molecular diagnosis of familial nonpolyposis colon cancer (EPCAM, MLH1, MSH2, MSH6, PMS2 genes)
Institut für Medizinische Genetik und angewandte Genomik Tübingen

FRANCE

ILE-DE-FRANCE
PARIS

Accréditation
Diagnostic du cancer du côlon héréditaire non polyposique (Panel)
CHU Paris Centre - Hôpital Cochin, Site Cochin

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

HAUTS-DE-FRANCE
LILLE

Accréditation
Diagnostic du syndrome de polypose intestinale (Panel)
CHRU de Lille - Centre de Biologie Pathologie Génétique

ESPAGNE

Cataluña
L'HOSPITALET DE LLOBREGAT

FRANCE

NORMANDIE
CAEN

ALLEMAGNE

Bayern
MÜNCHEN

FRANCE

OCCITANIE
TOULOUSE

FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

ESPAGNE

Cataluña
L'HOSPITALET DE LLOBREGAT

SUISSE

Suisse Romande
SION

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

ALLEMAGNE

Bayern
BAD STEBEN

FRANCE

BOURGOGNE-FRANCHE-COMTE
DIJON

ALLEMAGNE

Nordrhein-Westfalen
MÜNSTER

Molecular diagnosis of familial nonpolyposis colon cancer (MLH1, MSH2, MSH6, PMS2 genes)
Institut für Humangenetik des Universitätsklinikums Münster

ALLEMAGNE

Baden-Württemberg
STUTTGART

ALLEMAGNE

Sachsen
LEIPZIG

Molecular diagnosis of familial nonpolyposis colon cancer (MLH1, MSH2 and MSH6 genes)
Institut für Humangenetik am Universitätsklinikum Leipzig

FRANCE

GRAND-EST
STRASBOURG

Diagnostic des tumeurs du tube digestif (Panel)
CHU de Strasbourg - Hôpital de Hautepierre

ESPAGNE

País Vasco
SAN SEBASTIÁN

ALLEMAGNE

Sachsen
DRESDEN

Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Carl Gustav Carus an der TU Dresden

ALLEMAGNE

Baden-Württemberg
FREIBURG

Molecular diagnosis of familial nonpolyposis colon cancer (MLH1, MSH2, MSH6, PMS2 genes)
Institut für Humangenetik am Universitätsklinikum Freiburg

FRANCE

OCCITANIE
MONTPELLIER

Diagnostic de prédisposition au cancer colorectal (Panel)
CHRU de Montpellier - Hôpital Arnaud de Villeneuve

ESPAGNE

Cataluña
ESPLUGUES DE LLOBREGAT

ESPAGNE

Madrid
MADRID

Diagnosis of hereditary cancer (panel)
Fundación Jiménez Díaz

ESPAGNE

Cataluña
L'HOSPITALET DE LLOBREGAT

Diagnosis of inherited cancer risk (panel)
Institut Català d'Oncologia

ITALIE

PUGLIA
BARI

Molecular diagnosis of Muir-Torre syndrome (MSH2 gene)
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

CHYPRE

Cyprus
NICOSIA

Microsatelite instability for colorectal cancer syndromes
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Analysis for known mutations f colorectal cancer syndromes (hMLH1 3p22.2)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Mutation screening of colorectal cancer syndromes (hMLH1 3p22.2)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Analysis for known mutations of colorectal cancer syndromes (hMSH2 2p21)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Mutation screening of colorectal cancer syndromes (hMSH2 2p21)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Mutation screening of colorectal cancer syndromes (hPMS1 2q32.2)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

CHYPRE

Cyprus
NICOSIA

CHYPRE

Cyprus
NICOSIA

Mutation screening for colorectal cancer syndromes (hPMS2 7p22.1)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Mutation screening for colorectal cancer syndromes (hMSH6 2p16.3)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

CHYPRE

Cyprus
NICOSIA

Analysis of known mutations for colorectal cancer syndromes (MYH 1p34.1)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Mutation screening for colorectal cancer syndromes (MYH 1p34.1)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Immunohistochemistry for colorectal cancer syndromes (hMLH1 3p22.2)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Immunohistochemistry for colorectal cancer syndromes (hMSH2 2p21)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Immunohistochemistry for colorectal cancer syndromes (hMLH6)
The Cyprus Institute of Neurology and Genetics

CHYPRE

Cyprus
NICOSIA

Immunohistochemistry for colorectal cancer syndromes (hPMS2 7p22.1)
The Cyprus Institute of Neurology and Genetics

HONGRIE

Dél-Alföld
SZEGED

Muir-Torre syndrome
University of Szeged Deparment of Medical Genetics

ESPAGNE

Madrid
MADRID

Diagnosis of hereditary nonpolyposis colon cancer (MSH2, MSH6, PMS2 genes)
Centro Nacional de Investigaciones Oncológicas (CNIO)